MRNANASDAQLive delayed
$55.63
+1.56+2.89%
SourceCNBCAs ofJul 27, 2026, 8:00 PM
Delayed market data from CNBC. Not investment advice.
Moderna is a healthcare name tracked on StockWatch with delayed quotes, charts, and related news. Home market: United States.
Key statistics
Delayed fundamentals for MRNA · Finnhub.
- Market cap
- $22.14B
- P/E (TTM)
- —
- EPS (TTM)
- -$8.1462
- Div. yield
- —
- 52-week range
- $22.28 – $85.60
- Volume
- —
- Avg volume
- 5.01M
Price history
OHLC candles for MRNA · 3mo · 1d · Yahoo Finance · delayed · EMA / RSI
+18.01%periodDirect mentions, stories that impact this name, and related market themes — with Impact Analysis on each headline.
DirectHigh impactGlobalMostly neutralGoogle News
After Soaring Nearly 90% Thus Far in 2026, Is Moderna's Stock Still a Buy?After Soaring Nearly 90% Thus Far in 2026, Is Moderna's Stock Still a Buy? The Globe and MailBroad market headline — check whether risk appetite shifts.
Watch: MRNA · .SPX · .FTSE · .N225
DirectHigh impactGoogle News
Therapeutics Stocks Q1 Highlights: Moderna (NASDAQ:MRNA)DirectHigh impactGoogle News
Moderna (MRNA) Q2 2026 Preview: EPS Est. -$2.06, Reports July 31DirectHigh impactGoogle News
Weiss Asset Management LP Has $4.76 Million Position in Moderna, Inc. $MRNADirectHigh impactGoogle News
MRNA Stock Clocks Best Day In Over Two Months On Early-Stage Hantavirus Vaccine ResearchDirectHigh impactGoogle News
MRNA Stock Closes Down On Profit-Taking Following 20% Weekly Rally And Hantavirus BuzzDirectHigh impactGoogle News
Will Moderna (MRNA) Report Negative Earnings Next Week? What You Should KnowDirectHigh impactGoogle News
Moderna (MRNA) Stock Looks Above Fair Value After Cancer Trial News